Heart rate variability testing: could it change spending for rheumatoid arthritis patients in the United States? An exploratory economic analysis

References

• Crane MM, Juneja M, Allen J, et al. Epidemiology and treatment of new-onset and established rheumatoid arthritis in an insured US population. Arthritis Care Res 2015;67:1646-55
   PubMed Web of Science ®Google Scholar
• Birnbaum H, Pike C, Kaufman R, et al. Societal cost of rheumatoid arthritis patients in the US. Curr Med Res Opin 2010;26:77-90
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580-8
   PubMed Web of Science ®Google Scholar
• Kristiansen TM, Primdahl J, Antoft R, et al. Everyday life with rheumatoid arthritis and implications for patient education and clinical practice: a focus group study. Musculoskeletal Care 2012;10:29-38
   PubMedGoogle Scholar
• van Nies JAB, de Jong Z, van der Helm-van Mil AHM, et al. Improved treatment strategies reduce the increased mortality risk in early RA patients. Rheumatology 2010;49:2210-16
   PubMed Web of Science ®Google Scholar
• Moreland LW, Weinblatt ME, Keystone EC, et al. Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience. J Rheumatol 2006;33:854-61
   PubMed Web of Science ®Google Scholar
• Hazlewood GS, Barnabe C, Tomlinson G, et al. Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis. BMJ 2016;353:i1777
   PubMed Web of Science ®Google Scholar
• Stein PK, Bosner MS, Kleiger RE, et al. Heart rate variability: a measure of cardiac autonomic tone. Am Heart J 1994;127:1376-81
   PubMed Web of Science ®Google Scholar
• La Rovere MT, Pinna GD, Maestri R. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 2003;107:565-70
   PubMed Web of Science ®Google Scholar
• Dekker JM, Crow RS, Folsom AR, et al. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis Risk In Communities. Circulation 2000;102:1239-44
   PubMed Web of Science ®Google Scholar
• Tsuji H, Larson MG, Venditti FJ, et al. Impact of reduced heart rate variability on risk for cardiac events: the Framingham heart study. Circulation 1996;94:2850-5
   PubMed Web of Science ®Google Scholar
• Straub RH, Cutolo M. Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum 2007;56:399-408
   PubMed Web of Science ®Google Scholar
• di Comite G, Marinosci A, Di Matteo P, et al. Neuroendocrine modulation induced by selective blockade of TNF-alpha in rheumatoid arthritis. Ann N Y Acad Sci 2006;1069:428-37
   PubMed Web of Science ®Google Scholar
• Vassilopoulos D, Mantzoukis D. Dialogue between the brain and the immune system in inflammatory arthritis. Ann N Y Acad Sci 2006;1088:132-8
   PubMed Web of Science ®Google Scholar
• Aydemir M, Yazisiz V, Basarici I, et al. Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus. Lupus 2010;19:255-61
   PubMed Web of Science ®Google Scholar
• Nejad ZJ, Jamshidi AR, Qorbani M, et al. Cardiovascular autonomic neuropathy in rheumatoid arthritis assessed by cardiovascular autonomic function tests: a cross-sectional survey. Anatol J Cardiol 2015;15:722-6
   PubMed Web of Science ®Google Scholar
• Kiselev AR, Karavaev AS, Mironov SA, et al. The possibility of using spectral indices of heart rate variability to improve the diagnostic value of cardiovascular autonomic function tests in rheumatoid arthritis patients. Anatol J Cardiol 2015;15:510
   PubMed Web of Science ®Google Scholar
• Syngle V, Syngle A, Garg N, et al. Predictors of autonomic neuropathy in rheumatoid arthritis. Auton Neurosci Basic Clin 2016;201:54-9
   PubMed Web of Science ®Google Scholar
• Adlan AM, Veldhuijzen Van Zanten JJCS, Lip GYH, et al. Cardiovascular autonomic regulation, inflammation and pain in rheumatoid arthritis. Auton Neurosci Basic Clin 2017:1
   PubMed Web of Science ®Google Scholar
• Holman AJ, Ng E. Heart rate variability predicts anti-tumor necrosis factor therapy response for inflammatory arthritis. Auton Neurosci Basic Clin 2008;143:58-67
   PubMed Web of Science ®Google Scholar
• Holman AJ, Ng E. How substantive is heart rate variability as a predictor of anti-TNF treatment outcome for inflammatory arthritis? [abstract]. Arthritis Rheumatol 2015;67:#1571
   Web of Science ®Google Scholar
• Koopman FA, Chavan SS, Miljko S, et al. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc Natl Acad Sci 2016;113:8284-9
   PubMed Web of Science ®Google Scholar
• Shimizu M, Tachibana N, Hagasaka YGM. Obstructive sleep apnea (OSA) in RA patients and effect of CPAP on RA activity. [abstract]. Abstr Arthritis Rheum 2003. Available at: https://www.researchgate.net/publication/298302248_Obstructive_sleep_apnea_OSA_in_RA_patients_and_effect_of_CPAP_on_RA_activity
   PubMedGoogle Scholar
• Holman AJ, Ng E. Use of adjunctive neuroregulatory medication to improve etanercept treatment response for patients with inflammatory arthritis: a pilot study - ACR meeting abstracts. ACR/ARHP Annu Meet 2015:28-9
   Google Scholar
• Figorilli M, Puligheddu M, Congiu P, et al. The clinical importance of periodic leg movements in sleep. Curr Treat Options Neurol 2017;19:10
   PubMed Web of Science ®Google Scholar
• Fulda S. The role of periodic limb movements during sleep in restless legs syndrome: a selective update. Sleep Med Clin 2015;10:241-8
   PubMed Web of Science ®Google Scholar
• Izzi F, Placidi F, Romigi A, et al. Is autonomic nervous system involved in restless legs syndrome during wakefulness? Sleep Med 2014;15:1392-7
   PubMed Web of Science ®Google Scholar
• Ollendorf DA, Chapman R, Pearson SD, et al. Targeted immune modulators for rheumatoid arthritis: effectiveness & value. 2017. Available at: https://icer-review.org/wp-content/uploads/2016/08/NECEPAC_RA_Draft_Report_012017.pdf
   Google Scholar
• Curtis JR, Jain A, Askling J, et al. A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries. Semin Arthritis Rheum 2010;40:2-14.e1
   PubMed Web of Science ®Google Scholar
• Kim SC, Yelin E, Tonner C, et al. Changes in use of disease-modifying antirheumatic drugs for rheumatoid arthritis in the United States during 1983–2009. Arthritis Care Res 2013;65:1529-33
   Google Scholar
• Yang HK, Simoni-Wastila L, Zuckerman IH, et al. Benzodiazepine use and expenditures for Medicare beneficiaries and the implications of Medicare Part D exclusions. Psychiatr Serv 2008;59:384-91
   PubMed Web of Science ®Google Scholar
• Lee J, Pelkey R, Gubitosa J, et al. Comparing healthcare costs associated with oral and subcutaneous methotrexate or biologic therapy for rheumatoid arthritis in the United States. Am Heal Drug Benefits 2017;10:42-9
   PubMed Web of Science ®Google Scholar
• Wolfe F, Michaud K, Gefeller O, et al. Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum 2003;48:1530-42
   PubMed Web of Science ®Google Scholar
• Carlson JJ, Ogale S, Dejonckheere F, et al. Economic evaluation of tocilizumab monotherapy compared to adalimumab monotherapy in the treatment of severe active rheumatoid arthritis. Value Health 2015;18:173-9
   PubMed Web of Science ®Google Scholar
• Nguyen CM, Bounthavong M, Mendes MAS, et al. Cost utility of tumour necrosis factor-α inhibitors for rheumatoid arthritis. Pharmacoeconomics 2012;30:575-93
   PubMed Web of Science ®Google Scholar
• Gabay C, Emery P, van Vollenhoven R, et al. Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial. Lancet 2013;381:1541-50
   PubMed Web of Science ®Google Scholar
• Sanders GD, Neumann PJ, Basu A, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: Second panel on cost-effectiveness in health and medicine. JAMA 2016;316:1093-103
   PubMed Web of Science ®Google Scholar
• Mulcahy AW, Predmore Z, Mattke S. The cost savings potential of biosimilar drugs in the United States. Rand Corp 2014:16:1530-1542
   Google Scholar
• Elenkov IJ, Wilder RL, Chrousos GP, et al. The sympathetic nerve–an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000;52:595-638
   PubMed Web of Science ®Google Scholar
• Tracey KJD. The inflammatory reflex. Nature 2002;420:853-9
   PubMed Web of Science ®Google Scholar
• Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405:458-62
   PubMed Web of Science ®Google Scholar
• Levine YA, Koopman FA, Faltys M, et al. Neurostimulation of the cholinergic anti-inflammatory pathway ameliorates disease in rat collagen-induced arthritis. PLoS One 2014;9:1093-1103
   Web of Science ®Google Scholar
• Koopman FA, Tang MW, Vermeij J, et al. Autonomic dysfunction precedes development of rheumatoid arthritis: a prospective cohort study. EBioMedicine 2016;6:231-7
   PubMed Web of Science ®Google Scholar
• Koopman FA, van Maanen MA, Vervoordeldonk MJ, et al. Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis. J Intern Med 2017;282:64-75
   PubMed Web of Science ®Google Scholar
• van Maanen MA, Vervoordeldonk MJ, Tak PP. The cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritis. Nat Rev Rheumatol 2009;5:229-32
   PubMed Web of Science ®Google Scholar
• Adlan AM, Lip GYH, Paton JFR, et al. Autonomic function and rheumatoid arthritis-A systematic review. Semin Arthritis Rheum 2014;44:283-304
   PubMed Web of Science ®Google Scholar
• Koopman FA, Stoof SP, Straub RH, et al. Restoring the balance of the autonomic nervous system as an innovative approach to the treatment of rheumatoid arthritis. Mol Med 2011;17:937-48
   PubMed Web of Science ®Google Scholar
• del Rincón ID, Williams K, Stern MP, et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737-45
   PubMed Web of Science ®Google Scholar
• Holman AJ. An alternative, autonomic rationale for decreased risk of MI in patients with RA responsive to anti-TNF therapy: comment on article by Dixon [letter]. Arthritis Rheum 2008;58:1886
   PubMedGoogle Scholar
• Holman AJ. Considering cardiovascular mortality in patients with rheumatoid arthritis from a different perspective: a role for autonomic dysregulation and obstructive sleep apnea. J Rheumatol 2007;34:671-3
   PubMed Web of Science ®Google Scholar
• Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. Chest 1988;94:1200-4
   PubMed Web of Science ®Google Scholar
• Yazici Y, Shi N, John A. Utilization of biologic agents in rheumatoid arthritis in the United States: analysis of prescribing patterns in 16,752 newly diagnosed patients and patients new to biologic therapy. Bull NYU Hosp Jt Dis 2008;66:77-85
   PubMedGoogle Scholar
• Mennini FS, Marcellusi A, Gitto L, et al. Economic burden of rheumatoid arthritis in Italy: possible consequences on anti-citrullinated protein antibody-positive patients. Clin Drug Investig 2017
   PubMed Web of Science ®Google Scholar
• Jansen JP, Incerti D, Mutebi A, et al. Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators. J Med Econ 2017:1-12
   Web of Science ®Google Scholar